Jos G A Houbiers Selected Research

Org 37663

2/2010

The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jos G A Houbiers Research Topics

Disease

3	Rheumatoid Arthritis 09/2010 - 10/2007
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2021
1	Prostatitis 05/2017
1	Pelvic Pain 05/2017
1	Autoimmune Diseases (Autoimmune Disease) 09/2010

Drug/Important Bio-Agent (IBA)

2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 06/2021 - 05/2017
2	ASP3652IBA 06/2021 - 05/2017
1	human CHI3L1 proteinIBA 09/2010
1	AutoantigensIBA 09/2010
1	Methotrexate (Mexate)FDA LinkGeneric 02/2010
1	Estrogens (Estrogen)FDA Link 02/2010
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 02/2010
1	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2010
1	Org 37663IBA 02/2010
1	Estrogen Receptor alphaIBA 02/2010
1	EpitopesIBA 10/2007
1	Antirheumatic Agents (DMARD)IBA 10/2007
1	Biomarkers (Surrogate Marker)IBA 10/2007

Therapy/Procedure

1	Immunotherapy 09/2010
1	Intranasal Administration 09/2010
1	Therapeutics 10/2007